Abstract
In 1948, Kenneth Maxcy(69) wrote in a chapter on epidemiology, “The simplest of all infectious diseases is measles. ” That was before the virus had been isolated or any serological test had become available. Several complicating situations have been found in the intervening years, but they are rare, and Maxcy’s statement is true now, more than 30 years later, as it was then. This relative simplicity makes measles an ideal model for the study of infectious-disease epidemiology. Babbott and Gordon(5) reviewed our knowledge of measles epidemiology as of 1954. Much has been clarified since.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ABU BECR, M., A Discourse on the Smallpox and Measles (trans. R. Mead), J. Brindley, London, 1748.
ADAMS, J. M.,AND IMAGAWA, D. T., Measles antibodies in multiple sclerosis, Proc. Soc. Exp. Biol. Med. 111:562–566 (1962).
ALBRECHT, P., ENNIS, F. H., SALTZMEN, E. J., AND KRUGMAN, S., Persistence of maternal antibody beyond twelve months: Mechanisms of measles vaccine failure, J. Pediatr 91:766–767 (1977).
BABBOTT, F. L., GALBRAITH, N. S., MCDONALD, J. C., SHAW, A., AND ZUCKERMAN, A. J., Deaths from measles in England and Wales in 1961, Mon. Bull. Minist. Health Public Health Lab. Sew. 22:167–175 (1963).
Babbott, F. L., and Gordon, J. E., Modern measles, Am. J. Med. Sci. 228:334–361 (1954).
BAILEY, N. T. J., The Mathematical Theory of Epidemics, Griffin, London, 1957.
BARTLETT, M. S., Deterministic and stochastic models for recurrent epidemics, Third Berkeley Symp. Math. Stat. Prob. 4:81–109 (1956).
BARTLETT, M. S., Measles periodicity and community size, J. R. Stat. Soc. Ser. A 120:40–70 (1957).
BARTLETT, M. S., The critical community size for measles in the United States, J. R. Stat. Soc. Ser. A 123:37–44 (1960).
BECH, V., Studies on the development of complement fixing antibodies in measles patients, J. Immunol 83:267–275 (1959).
BECH, V., Measles epidemics in Greenland, Am.J. Dis. Child. 103:252–253 (1962).
BECH, V., The measles epidemic in Greenland, Arch. Gesamte Virusforsch. 16:53–56 (1965).
BELLANTI, J. A., SANG A, R. L., KLUTINIS, B., BRANDT, B., AND ARTENSTEIN, M. S., Antibody responses in serum and nasal secretion of children immunized with inactivated and attenuated measles virus vaccines, N. Engl. J. Med. 280:628–633 (1969).
Benjamin, B., and Ward, S. M., Leukocyte response to measles, Am. J. Dis. Child. 44:921–963 (1932).
BERG, R. B., AND ROSENTHAL, M. S., Propagation of measles virus in suspensions of human and monkey leukocytes, Proc. Soc. Exp. Biol. Med. 106:581–585 (1961).
BHATT, P. N., BRANDT, C. D., WEISS, R. A., Fox, J. P., AND SHAFFER, M. F., Viral infections of monkeys in their natural habitat in southern India, Am. J. Trop. Med. Hyg. 15:561–566 (1966).
BLACK, F. L., Serological epidemiology in measles, Yale J. Biol. Med. 32:44–50 (1959).
BLACK, F. L., Growth and stability of measles virus, Virology 7:184–192 (1959).
BLACK, F. L., A nationwide survey of United States military recruits, 1962. III. Measles and mumps antibodies, Am J. Hyg.80:304–307 (1964).
BLACK, F. L., Measles endemicity in insular populations: Critical community size and its evolutionary implication, Theor. Biol. 11:207–211 (1965).
BLACK, F. L., Measles, in: Manual of Clinical Microbiology 2nd ed. (E. H. LENNETTE AND J. P. TRUANT, eds.), American Society of Microbiology, Bethesda, Maryland, 1974.
BLACK, F. L., HIERHOLZER, W., WOOD ALL, J. P., AND PINHEIRO, F., Intensified reactions to measles vaccine in unexposed populations of American Indians J. Infect. Dis 124:306–317 (1971).
BLACK, F. L., AND ROSEN, L., Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure, J. Immunol. 88:725–731 (1962).
BLACK, F. L., AND SHERIDAN, S. R., Studies on attenuated measles-virus vaccine. IV. Administration of vaccine by several routes, N. Engl. J. Med. 263:166–170 (1960).
BLACK, F. L., AND SHERIDAN, S. R., Blood leukocyte response to live measles vaccine, Am. J. Dis. Child. 113:301–304 (1967).
BLAKE, F. C., AND TRASK, J. D., Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected, J. Exp. Med. 33:413–422 (1921).
BRIDGES, E. L., Uttermost Part of the Earth, Dutton, New York, 1949.
BROWN, P., BASRIGHT, M., AND GAJDUSEK, D. C., Response to live attenuated measles vaccine in susceptible island populations in Micronesia, Am.J. Epidemiol. 82:115–122 (1965).
BROWN, P. D., GAJDUSEK, C., ANDTSAI, T., Persistence of measles antibody in the absence of circulating natural virus five years after immunization of a virgin population with Edmonston B vaccine, Am J. Epidemiol 90:514–518 (1969).
CELERS, J., Problèmes de santé publique posés par la rougeole dans les pay favorisés, Arch. Gesamte Virusforsch. 16:5–18 (1965).
Center for Disease Control, Atypical measles—California 1974–1975, Morbid. Mortal. Weekly Rep. 25:245–246 (1976).
CHALMERS, A. K., The Health of Glasgow 1818–1925, Bell and Bain, Glasgow, 1930.
CHERRY, J. D., FEIGIN, R. D., LOBES, L. A., JR., HIN- THORN, D. R., SHACKLEFORD, P. G., SHIRLEY, R. H., LINS, R. D., AND CHOI, S. C., Urban measles in the vaccine era: A clinical, epidemiologic and serologic study, J. Pediatr. 81:217–230 (1972).
CHRISTENSEN, P. E., HENNING, S., BANG, H. O., ANDERSEN, V., JORDAL, B., AND JENSEN, O., An epidemic of measles in southern Greenland, 1951: Measles in virgin soil. II. The epidemic proper, Acta Med. Scand. 144:430–449 (1952).
CIONGOLI, A. K., PLATZ, P., DUPONT, B., SVEJGAARD, A., FOG, T., AND JERSLID, C., Lack of antigen response to myxoviruses in multiple sclerosis, Lancet 2:1147 (1973).
Cook, S. D., Dowling, P. D., and Russell, W. C, Multiple sclerosis and canine distemper, Lancet 1:605–606 (1978).
CORNEY, B. G., The behavior of certain epidemic diseases in natives of Polynesia with especial reference to the Fiji Islands, Trans. Epidemiol. Soc. London (N. Ser.) 3:76–95 (1884).
DESEDA-TOUS, J., CHERRY, J. D., SPENCER, M. J., WIL- LIVER, R. C., BOYER, K. M., DUDLEY, J. P., ZAHRADNIK, J. M., KRAUSE, P. J., AND WALBERGH, E. W., Measles revaccination, persistence and degree of antibody titer by type of immune response, Am.J. Dis. Child. 132:287–290 (1978).
DETELS, R., BRODY, J. A., MCNEW, J., AND EDGAR, A. H., Further epidemiological studies of sub-acute sclerosing panencephalitis, Lancet 2:11–14 (1973).
ENDERS, J. F., AND PEEBLES, T. C, Propagation in tissue cultures of cytopathogenic agents from patients with measles, Proc. Soc. Exp. Biol. Med. 86:277–286 (1954).
FENNER, F., The Impact of Civilization on the Biology of Man (S. V. BOYDEN, ed.), University of Toronto Press, Toronto, 1970.
Fox, J. P., BLACK, F. L., AND KOGON, A., Measles and readiness for reading and learning. V. Evaluative comparison of the studies and overall conclusions, Am. J. Epidemiol. 88:168–175 (1969).
FULGINITI, V. A., ELLER, J. J., DOWNIE, A. W., AND KEMPE, C. H., Altered reactivity to measles virus: Atypical measles in children previously immunized with inactivated measles virus vaccines, J. Am. Med. Assoc. 202:1075–1080 (1967).
GALLAGHER, M., AND FLANAGAN, T. D., Growth of measles in continuous lymphoid cell lines, Fed. Proc. Fed. Am. Soc. Exp. Biol. 34:948 (1975).
GIBBS, F. A., GIBBS, E. L., CARPENTER, P. R., AND SPIES, H. W., Electroencephalographic abnormality in “uncomplicated” childhood diseases, J. Am. Med. Assoc. 171:1050–1055 (1959).
GORDON, J. E., JANSSEN, A. A. J., AND ASCOLI, W., Measles in rural Guatemala, J. Pediatr. 66:779–786 (1965).
GREENBERG, M., PELLITTERI, O., AND EISENSTEIN, D., T., Measles encephalitis. 1. Prophylactic effect of gamma globulin, J. Pediatr. 46:642–647 (1955).
GRESSER, I., AND KATZ, S. L., Isolation of measles virus from urine, N. Engl. J. Med. 263:452–454 (1960).
GRIFFITHS, D. A., The effect of measles vaccination on the incidence of measles in the community, J. R. Stat. Soc. Ser. A 136:441–449 (1973).
GULICK, L. H., On the climate, diseases and materia medica of the Sandwich (Hawaiian) Islands, N. Y. J. Med. 14:169–211 (1855).
HALL, W. W., AND MARTIN, S. J., The structural proteins of measles virus, in: Negative Strand Viruses (B. W. J. MAHY AND R. D. BARRY, eds.), pp. 89–103, Academic Press, London, 1975.
HAMER, W. H., The Milroy lectures on epidemic disease in England—The evidence of variability and persistency of type, Lancet 1:733–739 (1906).
HEDRICK, A. W., Monthly estimates of the child population susceptible to measles 1900–1931, Am.J. Hyg. 17:613–636 (1933).
HELMS, S., AND HELMS, P., Tuberculin sensitivity during measles, Acta Tuberc. Scand. 35:166–171 (1956).
HIRSCH, A., Handbook of Geographical and Historical Pathology Vol. 1, pp. 154–170, New Sydenham Society, London, 1883.
HOME, F., Medical Facts and Experiments A. Millar, London, 1759.
Horta-Barbosa, L., Fuccilo, D. A., Hamilton, R.,TRAUB, R., LEY, A., AND SEVER, J. L., Some characteristics of SSPE measles virus, Proc. Soc. Exp. Biol. Med. 134:17–21 (1970).
deJong, J. G., and Winkler, K. O., Survival of measles virus in air, Nature (London) 201:1054–1055 (1964).
KATZ, S. L., AND ENDERS, J. F., Measles virus, in: Diagnostic Procedures for Viral and Rickettsial Infections 4th ed. (E. H. LENNETTE AND N. J. SCHMIDT, eds.), pp. 504–528, American Public Health Association, New York, 1969.
KATZ, S. L., KEMPE, C. H., BLACK, F. L., LEPOW, M. L., KRUGMAN, S., HAGGERTY, R. J., AND ENDERS, J. F., Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccination, N. Engl. J. Med. 273:180–184 (1960).
KOPROWSKI, H., The role of hyperergy in measles encephalitis, Am. J. Dis. Child. 103:273–278 (1962).
KRAUSE, P. J., CHERRY, J. D., NAIDITCH, M. J., DESADA-TOUS, J., AND WALBERGH, E. W., Revaccina- tion of previous recipients of killed measles vaccine: Clinical and immunological studies, J. Pediatr. 93: 565–571 (1978).
KRESS, S., SCHLUEDERBERG, A. E., HORNICK, R. B., MORSE, L. J., COLE, J. L., SLATER, E. A., AND MCCRUMB, F. R., Studies with live attenuated measles-virus vaccine. II. Clinical and immunological response of children in an open community, Am. J. Dis. Child. 101:701–707 (1961).
KRUGMAN, S., GILES, J. P., JACOBS, A. M., AND FRIEDMAN, H., Studies with a further attenuated live mea- sles-virus vaccine, Pediatrics 66:471–488 (1965).
KRUGMAN, S., Present status of measles and rubella immunization in the United States: A medical progress report, J. Pediatr. 90:1–12 (1977).
Landlaekni, Heilbrigdisskyslur (Public Health in Iceland, Rikisprentsmidjan Gutenberg, Reykjavik, 1941–1950.
LEPOW, M. L., AND NANKERVIS, G. A., Eight-year serological evaluation of Edmonston live measles vaccine, J. Pediatr. 75:407–411 (1969).
LIAN, J.-F., Quantitative approach to measles humoral immunity, Ph.D. Dissertation, Yale University, 1979.
MAXCY, K. F., Principles and methods of epidemiology, in: Viral and Rickettsial Infections of Man (T. M. RIVERS, ed.), pp. 128–146, Lippincott, Philadelphia, 1948.
MCCRUMB, F. R., KRESS, S., SAUNDERS, E., SNYDER, M. J., AND SCHLUEDERBERG, A. E., Studies with live attenuated measles vaccine. I. Clinical and immunological responses in institutionalized children, Am. J. Dis. Child. 101:689–700 (1961).
MCNEILL, W. H., Plagues and Peoples: A Natural History of Infectious Diseases, Doubleday, New York, 1976.
Measles Sub-committe: Committee on Development of Vaccines and Immunization Procedures, CLINICAL TRIAL OF LIVE MEASLES VACCINE GIVEN ALONE AND LIVE VACCINE PRECEDED BY KILLED VACCINE, LANCET 2:571–575 (1977).
Measles—United States, first 36 weeks, 1977–1978, Morbid. Mortal. Weekly Rep. 27:235–237 (1978).
TER MEULEN, V., MüLLER, D., KäCKELL, Y., KATZ, M., AND MAYERMANN, R., Isolation of infectious measles virus in measles encephalitis, Lancet 2:1172–1175 (1972).
MEYER, H. M., Mass vaccination against measles in Upper Volta, Arch. Gesamte Virusforsch. 16:243–245 (1965).
MORLEY, D., The severe measles of West Africa, Proc. R. Soc. Med. 57:846–849 (1969).
MYERS, J. M., Assimilation to the ecological and social systems of a community, Am. Sociol. Rev. 15:367–370 (1950).
NATHANSON, N., AND MILLER, A., Epidemiology of multiple sclerosis: Critique of the evidence for a viral etiology, Am.J. Epidemiol 107:451–461 (1978).
NATHANSON, N., YORKE, J. A., PIANIGIANI, G., AND MARTIN, J., Requirements for perpetuation and eradication of viruses in populations, in: Persistent Viruses (J. D. STEVENS, G. J. TODARO, AND C. F. FOY, eds.), pp. 75–100, Academic Press, New York, 1978.
NEEL, J. V., CENTERWALL, W. R., CHAGNON, N. A., AND CASEY, H. L., Notes on the effects of meaSles in virgin-soil population of South American Indians, Am.J. Epidemiol 91:418–429 (1970).
NORRBY, E., Viral antibodies in multiple sclerosis, Prog. Med. Virol 24:1–39 (1978).
NORRBY, E., ENDERS-RUCKLE, G., AND TER MEULEN, V., Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus, J. Infect. Dis. 132:262–269 (1975).
NUTELS, N., Medical problems of newly contacted Indian groups, Pan. Am. Health Organ. Sei. Publ. 165:68–76 (1968).
OFFNER, H., AMMITZBOLL, T., CLAUSEN, J., FOG, F., HYLLESTED, K., AND EINSTEIN, E., Immune response of lymphocytes from patients with multiple sclerosis to phytohemagglutinin, basic protein myelin and measles antigens, Acta. Neurol Scand. 50:373–381 (1974).
PAMPIGLIONE, G., Prodromal phase of measles: Some neurophysiological studies, Br. Med. J. 2:1296–1300 (1964).
PANUM, P. L., Observations Made During the Epidemic of Measles on the Faroe Islands in the Year 1846, American Publishing Association, New York, 1940.
PAPP, K., Experiences prouvant que a voie d’infection de la rougeole est la contamination de la muguese conjontivale, Rev. d’lmmunol. 20:27–36 (1956).
PATY, D. W., FURESZ, J., BOUCHER, W., RAND, C. G., AND STILLER, C. R., Measles antibodies as related to HLA types in multiple sclerosis, Neurology 20:651–655 (1976).
PAYNE, F. E., AND BAUBLIS, J. V., Decreased reactivity of SSPE strains of measles virus with antibody, J. Infect. Dis. 127:505–511 (1973).
PEART, A. F. W., AND NAGLER, F. P., Measles in the Canadian Arctic 1952, Can. J. Public Health 45:146–157 (1954).
RAWLS, W. E., RAWLS, M. L., AND CHERNESKY, M. H., Analysis of a measles epidemic: Possible role of vaccine failures, Can. Med. Assoc. J. 113:941–944 (1975).
RISTORI, C., BOCCARDO, H., BORGONO, J. M., AND AR- MIJO, R., Medical importance of measles in Chile, Am.J. Dis. Child. 103:236–241 (1962).
RUCKDESCHEL, J. C., GRAZIANO, K. D., AND MARDINEY, M. R., JR., Additional evidence that the cell-associated immune system is the primary host defense against measles, Cell Immunol 17:11–18 (1975).
SALMI, A. A., NORRBY, E., AND PANELIUS, M., Identification of different measles virus-specific antibodies in the serum and cerebro-spinal fluid from patients with sub-acute sclerosing panencephalitis and multiple sclerosis, Infect. Immun. 6:248–254 (1972).
SCHLUEDERBERG, A. E., Immune globulins in human viral infections, Nature (London) 205:1232–1233 (1965).
SCHUTZ, F., Die Epidemiologic der Masern Gustav Fisher, Jena, 1925.
SCRIMSHAW, N. S., SOLOMON, J. B., BRUCH, H. A., AND GORDON, J. E., Studies of diarrheal disease in Central America. VIII. Measles, diarrhea and nutritional deficiency in Guatemala, Am. J. Trop. Med. 15:625–631 (1966).
SHASBY, D. M., SHOPE, T. C., DOWNS, H., HERRMANN, K. L., AND POLKOWSKI, J., Epidemic measles in a highly vaccinated population, N. Engl J. Med. 296:585–589 (1977).
SOPER, H. E., The interpretation of periodicity in disease prevalence, J. R. Stat. Soc. Ser. A 92:34–61 (1929).
SURINGA, D. W. R., BANK, L. J., AND ACKERMAN, A. B., Role of measles in skin lesions and Koplik spots, N. Engl. J. Med. 283:1139–1142 (1970).
SYDENHAM, T., The Works of Thomas Sydenham Vol. 2, pp. 250–251, Sydenham Society, London, 1922.
TOOTH, J. S. H., AND LEWIS, I. C., Measles epidemic in a primitive isolated community, Med. J. Aust. 1:182–186 (1963).
UTERMOHLEN, V., AND ZABRISKIE, J. B., A suppression of cellular immunity in patients with multiple sclerosis, J. Exp. Med. 138:1591–1596 (1973).
Valdimarsson, H., Agnarsdottir, G., and Lach- mann, P. J., MEASLES VIRUS RECEPTOR ON HUMAN T LYMPHOCYTES, NATURE (LONDON) 225:554–556 (1975).
VIEIRA, J. P. B., JR., Vacinacäo dos indios Surui contrâ o sarapo, Rev. Assoc. Med. Brazil 16:183–186 (1968).
WORLD HEALTH ORGANIZATION, Measles immunity in the first year after birth and the optimum age forvaccination in Kenyan children, WHO Bull 55:21–31 (1977).
YEAGER, A. S., DAVIS, J. H., Ross, L. A., AND HARVEY, B. S., Measles immunization successes and failures, J. Am. Med. Assoc. 237:347–351(1977)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Black, F.L. (1982). Measles. In: Evans, A.S. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3237-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3237-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3239-8
Online ISBN: 978-1-4613-3237-4
eBook Packages: Springer Book Archive